Skip to content

Personalized Care enabled by activity monitoring

Personalized Care enabled by activity monitoring - Activity monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33422
Enrollment
320
Registered
2009-04-14
Start date
2009-02-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementie en kwetsbare ouderen, allen cliënten van thuiszorgorganisaties dementia frail elderly

Interventions

QuietCare system, activity monitoring

Sponsors

Proteion Thuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The person lives independently at home and receives home care by Proteion Thuis or Savant. - The person lives in independently in the community or in sheltered housing. - The person is a frail elderly (with a GFI score > 4) or recieves care based on psycho-geriatric indication authorised by Centrum Indicatiestelling Zorg (CIZ).

Exclusion criteria

Exclusion criteria: - no phone line available at home - for the group of dementia: - young dementia (age

Design outcomes

Primary

MeasureTime frame
- Living independently and self-management (GARS), quality of life (EQ-5D), loneliness and feeling of safety and use of care of clients. - The objective and subjective burden of informal caregivers (OBM, SCI en SBR). - The work satisfaction of formal caregivers.

Secondary

MeasureTime frame
(1) What are the technical specifications of the QuietCare system? (2) Is the QuietCare system reliable and valid? (3) To what extend do health care organizations and formal caregivers respond according to the established protocol? (4) What are the costs of the implementation and use of the QuietCare system for the care organizations? (5) What are the consequences of the QuietCare system for health care organizations?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)